EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching

Noritoshi Enatsu iD, Kunihiro Enatsu, Yihsien Enatsu, Ai Yamada, Koji Yamada, Nao Hayashi, Eri Okamoto, Shoji Kokeguchi, Hiroaki Shibahara iD, Masahide Shiotani

Reproductive Medicine and Biology · 2026-01 · 25 (1)

DOI: 10.1002/rmb2.70060 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 13.05.2026. Verfasst von Noritoshi Enatsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hanabusa Women's Clinic Kobe city Japan. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare clinical outcomes of ART cycles stimulated with follitropin delta, follitropin alpha, or human menopausal gonadotropin (hMG) using a single‐center retrospective cohort with propensity score matching (PSM).

Methods

We analyzed 20 809 ART cycles (2021–2024). PSM adjusted for age, body weight, anti‐Müllerian hormone, antral follicle count, prior ART attempts, stimulation protocol, and trigger method. The matched cohort comprised 7,647 cycles (2549/group). The primary outcome was oocyte yield. Secondary outcomes included blastocyst development, ovarian enlargement ≥ 5 cm, and clinical pregnancy rates.

Results

The primary outcome regarding oocyte yield was statistically indeterminate across different analytical approaches, and the observed differences were clinically marginal. Both recombinant FSH preparations showed higher blastocyst yields and a lower observed incidence of ovarian enlargement ≥ 5 cm compared with hMG; the latter finding, however, does not establish a clinical safety advantage because clinically diagnosed OHSS was not evaluated. Clinical pregnancy rates were comparable among the three groups.

Conclusions

Differences in oocyte yield among follitropin delta, follitropin alpha, and hMG were small and statistically inconsistent. Secondary findings should be interpreted as exploratory, suggesting broadly comparable clinical performance among the three gonadotropin preparations.

Autor:innen und Institutionen

  • Hanabusa Women's Clinic Kobe city Japan.

ORCID-Profile: Noritoshi Enatsu, Hiroaki Shibahara

Zitieren

APA

Enatsu, N., Enatsu, K., Enatsu, Y., Yamada, A., Yamada, K., Hayashi, N., Okamoto, E., Kokeguchi, S., Shibahara, H., & Shiotani, M. (2026). Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70060

Vancouver

Enatsu N, Enatsu K, Enatsu Y, Yamada A, Yamada K, Hayashi N, et al. Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70060

BibTeX
@article{Enatsu2026,
  author = {Enatsu, Noritoshi and Enatsu, Kunihiro and Enatsu, Yihsien and Yamada, Ai and Yamada, Koji and Hayashi, Nao and Okamoto, Eri and Kokeguchi, Shoji and Shibahara, Hiroaki and Shiotani, Masahide},
  title = {Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching},
  journal = {Reproductive Medicine and Biology},
  year = {2026},
  volume = {25},
  number = {1},
  doi = {10.1002/rmb2.70060}
}
Kostenlos starten →